Cargando…

Incremental Health Care Burden of Bleeding Among Patients with Venous Thromboembolism in the United States

BACKGROUND: The health care and economic burden of venous thromboembolism (VTE) has been evaluated in regard to acute VTE, VTE recurrence, and some VTE complications, such as postthrombotic syndrome, but the cost burden attributed to bleedings is not well understood. OBJECTIVE: To evaluate health ca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Amin, Alpesh, Bruno, Amanda, Trocio, Jeffrey, Lin, Jay, Lingohr-Smith, Melissa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Managed Care Pharmacy 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398280/ https://www.ncbi.nlm.nih.gov/pubmed/26402395 http://dx.doi.org/10.18553/jmcp.2015.21.10.965

Ejemplares similares

Incremental Health Care Resource Utilization and Economic Burden of Venous Thromboembolism Recurrence from a U.S. Payer Perspective
por: Lin, J., et al.
Publicado: (2014)

Venous Thromboembolism Prophylaxis and Risk for Acutely Medically Ill Patients Stratified by Different Ages and Renal Disease Status
por: Amin, Alpesh, et al.
Publicado: (2019)

Influence of the duration of hospital length of stay on frequency of prophylaxis and risk for venous thromboembolism among patients hospitalized for acute medical illnesses in the USA
por: Amin, Alpesh, et al.
Publicado: (2019)

All-Cause, Stroke/Systemic Embolism–, and Major Bleeding-Related Health-Care Costs Among Elderly Patients With Nonvalvular Atrial Fibrillation Treated With Oral Anticoagulants
por: Deitelzweig, Steve, et al.
Publicado: (2018)

Hospital Resource Utilization and Costs Associated With Warfarin Versus Apixaban Treatment Among Patients Hospitalized for Venous Thromboembolism in the United States
por: Deitelzweig, Steven, et al.
Publicado: (2018)

High Burden of 30‐Day Readmissions After Acute Venous Thromboembolism in the United States
por: Secemsky, Eric A., et al.
Publicado: (2018)

Economic Burden of Treatment‐Resistant Depression Among Patients Hospitalized for Major Depressive Disorder in the United States
por: Lin, Jay, et al.
Publicado: (2019)

Bleeding risk assessment for venous thromboembolism prophylaxis
por: Chindamo, Maria Chiara, et al.
Publicado: (2021)

Systematic literature review of treatment patterns for venous thromboembolism patients during transitions from inpatient to post-discharge settings
por: Trocio, Jeffrey, et al.
Publicado: (2018)

Contrasts in Glioblastoma—Venous Thromboembolism versus Bleeding Risk
por: Muster, Viktoria, et al.
Publicado: (2021)

Biomarkers of bleeding and venous thromboembolism in patients with acute leukemia
por: Hisada, Yohei, et al.
Publicado: (2023)

Incremental cost burden among patients with severe uncontrolled asthma in the United States
por: Burnette, Autumn, et al.
Publicado: (2023)

Venous Thromboembolism Prophylaxis in the United States: Still Room for Improvement
por: Sliwka, Diane, et al.
Publicado: (2010)

Burden of venous thromboembolism in patients with pancreatic cancer
por: Frere, Corinne
Publicado: (2021)

Risk assessment of venous thromboembolism and bleeding in COVID‐19 patients
por: Wang, Lan, et al.
Publicado: (2022)

Bleeding outcomes in thrombocytopenic acute leukemic patients with venous thromboembolism
por: Wilson, Nathaniel R., et al.
Publicado: (2020)

Evaluation of the predictive value of the bleeding prediction score VTE‐BLEED for recurrent venous thromboembolism
por: Klok, Frederikus A., et al.
Publicado: (2019)

Locoregional therapy patterns and healthcare economic burden of patients with hepatocellular carcinoma in the USA
por: Aly, Abdalla, et al.
Publicado: (2021)

Treatment Patterns and Antipsychotic Medication Adherence Among Commercially Insured Patients With Schizoaffective Disorder in the United States
por: Joshi, Kruti, et al.
Publicado: (2016)

Real-World Adherence to Antiretroviral Therapy Among HIV-1 Patients Across the United States
por: McComsey, Grace A., et al.
Publicado: (2021)

Prediction of Major Bleeding in Anticoagulated Patients for Venous Thromboembolism: Comparison of the RIETE and the VTE-BLEED Scores
por: Lecumberri, Ramón, et al.
Publicado: (2021)

COVID-19–associated venous thromboembolism: risk of recurrence and major bleeding
por: Demelo-Rodriguez, Pablo, et al.
Publicado: (2023)

Impact of a Program to Improve Venous Thromboembolism Prophylaxis on Incidence of Thromboembolism and Bleeding Rates in Hospitalized Patients During Implementation of Programs to Improve Venous Thromboembolism Prophylaxis
por: Lovely, Jenna K., et al.
Publicado: (2020)

Comparison of Four Bleeding Risk Scores to Identify Rivaroxaban‐treated Patients With Venous Thromboembolism at Low Risk for Major Bleeding
por: Kline, Jeffrey A., et al.
Publicado: (2016)

Rate of deep-vein thrombosis and pulmonary embolism during the care continuum in patients with acute ischemic stroke in the United States
por: Amin, Alpesh N, et al.
Publicado: (2013)

Longitudinal Evaluation of Health Plan Cost per Venous Thromboembolism or Bleed Event in Patients With a Prior Venous Thromboembolism Event During Hospitalization
por: Bullano, Michael F., et al.
Publicado: (2005)

Health care costs associated with venous thromboembolism in selected high-risk ambulatory patients with solid tumors undergoing chemotherapy in the United States
por: Khorana, Alok A, et al.
Publicado: (2013)

D-Dimer Measured at Diagnosis of Venous Thromboembolism is Associated with Risk of Major Bleeding
por: Johnsen, Håkon S., et al.
Publicado: (2019)

Bleeding risk in patients with venous thromboembolic events treated with new oral anticoagulants
por: Wallvik, Niklas, et al.
Publicado: (2020)

Bleeding in women with venous thromboembolism during pregnancy: A systematic review of the literature
por: Simard, Camille, et al.
Publicado: (2022)

Incidence and clinical impact of bleeding events in older patients with acute venous thromboembolism
por: Ferrazzini, Elisa, et al.
Publicado: (2022)

Recurrent venous thromboembolism and bleeding with extended anticoagulation: the VTE-PREDICT risk score
por: de Winter, Maria A, et al.
Publicado: (2023)

Assessment of bleeding risk in cancer patients treated with anticoagulants for venous thromboembolic events
por: Poénou, Géraldine, et al.
Publicado: (2023)

Yearly trend of acute venous thromboembolism in patients admitted with heart failure in the United States
por: Basnet, Sijan, et al.
Publicado: (2019)

Recurrent thromboembolism, bleeding, and mortality in Asian patients with venous thromboembolism receiving different oral anticoagulants: A nationwide analysis
por: Lee, Mei-Chuan, et al.
Publicado: (2022)

The burden and predictors of venous thromboembolic diseases in patients with multiple primary malignancies
por: Alhamadh, Moustafa S., et al.
Publicado: (2022)

Prevalence of Venous Thromboembolism in Intensive Care Units: A Meta-Analysis
por: Gao, Xiaoyu, et al.
Publicado: (2022)

Estimated prevalence of undiagnosed atrial fibrillation in the United States
por: Turakhia, Mintu P., et al.
Publicado: (2018)

Venous thromboembolism /
por: Hirsh, Jack, 1935-
Publicado: (1981)

Risk of Venous Thromboembolism in Glioblastoma Patients
por: Lim, Gerald, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_6nl54tr12e2qgedqjf1tjmviob